There is a chance that, one day, this company will be taken over. It will also pop when J&J gets the OK on the Animus/Dexcom artificial pancreas which is before the FDA. The future will probably bring respectable increases in quarter by quarter sales and their first profitable quarter; they are already cash flow positive. They dominate the CGM market, so I don't think competition is a worry. They have just scratched the surface of foreign sales. These are the positives.
All of the above should increase the price, but from what base? If the market corrects, so will the price of DXCM. Also, insiders have been dumping shares like crazy, check it out.
If you are willing to hold for the long term you should do well. The call is yours, good luck.
Thanks tmcg1367, that was quite an insight. I read similar sentiments on DXCM so just on the fence on to dump or keep it. I'll keep it till year end to see how it flows. I am sure a lot more news will be coming out on them.